This phase is then followed by HBeAg-positive chronic hepatitis, characterized by elevated ALT and reduction in serum HBV-DNA, reflecting the activation of an antiviral immune response that can constrain viral replication [8]. This evidence concerns the gene GPT and chronic hepatitis.